News and Stories

Phenylephrine is the most popular oral decongestant in the country, but further scrutiny by scientists has found that the ingredient is actually no better than a placebo.

Chris Casey | September 19, 2023

Scientists at the University of Colorado Anschutz Medical Campus have made a `paradigm shifting’ discovery on the mechanisms required for learning and memory that could lead to new therapies for Alzheimer’s disease and potentially Down syndrome.

David Kelly | August 30, 2023

The recent Food and Drug Administration approval of the nasal spray Narcan is good news for music festival attendees hoping to carry the medication in case they witness an opioid overdose.

Laura Kelley | March 30, 2023

Growing up in a family of machinists, Carlos Catalano was fascinated by the inner workings of devices. Wrist watches, especially, weren’t safe around the family home in Southern California.

Chris Casey | October 05, 2022

Could oxidative stress, a condition known to cause inflammation and cellular breakdown, impact the trajectory of Down syndrome cell development?

Guest Contributor | July 19, 2022

A new study published in today’s issue of Biochemistry is the first to explore the effects of multiple mutations in the evolution of SARS-CoV-2 variants. The findings can help scientists better understand the properties of current and new variants.

Julia Milzer | June 07, 2022

The University of Colorado Anschutz Medical Campus is a leader in the field of integrating pharmacogenomics into clinical care.

Megan Lane | May 17, 2022